ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 1206

$461K Total Retail Price of All Prescriptions

Rank: 208 out of 1206

530 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 530 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,887 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 701 581 1 2
OMEPRAZOLE 483 403 2 3
FUROSEMIDE 377 361 3 5
ATENOLOL 370 317 4 14
SIMVASTATIN 369 292 5 1
AMLODIPINE BESYLATE 326 282 6 6
POTASSIUM CHLORIDE 316 305 7 12
TRAMADOL HCL 280 265 8 17
METOPROLOL TARTRATE 245 192 9 9
METOPROLOL SUCCINATE 238 225 10 15
ENALAPRIL MALEATE 229 210 11 45
WARFARIN SODIUM 198 197 12 8
LISINOPRIL 186 142 13 4
PRAVASTATIN SODIUM 170 158 14 21
METFORMIN HCL 163 95 15 10
TRIAMTERENE-HCTZ 158 113 16 33
ZOLPIDEM TARTRATE 137 132 17 25
LOSARTAN POTASSIUM 124 121 18 20
ALLOPURINOL 117 117 19 24
SERTRALINE HCL 110 101 20 22
DIGOXIN 108 108 21 43
LANTUS 108 106 21 38
METFORMIN HCL ER 106 94 23 58
HYDROCODONE-ACETAMINOPHEN 104 84 S3 24 7
CEPHALEXIN 102 91 25 62
HYDROCHLOROTHIAZIDE 101 96 26 11
BUMETANIDE 97 97 27 101
ATORVASTATIN CALCIUM 95 75 28 13
RANITIDINE HCL 94 67 29 23
TAMSULOSIN HCL 94 65 29 26
GLIMEPIRIDE 87 51 31 34
FINASTERIDE 87 84 31 90
TRAZODONE HCL 87 76 31 37
AZITHROMYCIN 86 70 34 46
DILTIAZEM ER 77 64 35 83
POLYETHYLENE GLYCOL 3350 75 54 36 31
ADVAIR DISKUS 74 51 37 55
VERAPAMIL ER 73 73 38 97
CITALOPRAM HBR 72 69 39 16
GABAPENTIN 70 70 40 18
ISOSORBIDE MONONITRATE ER 70 70 40 40
KLOR-CON 10 67 49 42 93
FLUTICASONE PROPIONATE 66 66 43 42
CARVEDILOL 66 54 43 32
CALCITONIN-SALMON 61 61 45 250
OXYBUTYNIN CHLORIDE 57 56 46 68
CEFUROXIME 57 51 46 157
TORSEMIDE 54 54 48 144
PROAIR HFA 53 53 49 49
BENAZEPRIL HCL 52 52 50 39
FLOVENT HFA 52 52 50 228
NAMENDA 52 52 50 36
PRIMIDONE 50 30 53 226
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.